Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02072421 · ClinicalTrials.gov registry record · NA
The MASS COMM Post-Randomization Phase Cohort Study
A NA study, sponsored by Baim Institute for Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 2,879
- Enrollment target
NCT02072421 is a NA study that has completed, run by Baim Institute for Clinical Research. The registered enrollment target is 2,879 participants.
The verdict
NCT02072421, a NA study, has completed, sponsored by Baim Institute for Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,879 participants
- Enrollment target
Study Summary
The primary objective of the Post-Randomization Phase Cohort Study is to continue to assess the safety of non-emergency PCI performed at hospitals without cardiac surgery on-site in patients with myocardial ischemia (other than ST-segment elevation myocardial infarction \[STEMI\]).
Interventions
- PROCEDURE PCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,879 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02072421
The ClinicalTrials.gov registry entry for NCT02072421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,879 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baim Institute for Clinical Research, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PCI is the first listed.
NCT02072421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02072421 about?
NCT02072421 is a clinical study titled "The MASS COMM Post-Randomization Phase Cohort Study". The primary objective of the Post-Randomization Phase Cohort Study is to continue to assess the safety of non-emergency PCI performed at hospitals without cardiac surgery on-site in patients with myocardial ischemia (other than ST-segment elevation myocardial infarction \[STEMI\]).
What is the current status of trial NCT02072421?
This trial is currently completed. It is a NA study. The enrollment target is 2,879 participants. The study started on 2011-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02072421?
The interventions under investigation include: PCI (PROCEDURE).
Who is sponsoring clinical trial NCT02072421?
This trial is sponsored by Baim Institute for Clinical Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.